Cell specific tumor suppressor effect of Hsa-miR-1226-3p through downregulation of HER2, PIK3R2, and AKT1 genes
Author:
Funder
INSF
Publisher
Elsevier BV
Subject
Cell Biology,Biochemistry
Reference33 articles.
1. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges;Butti;Mol. Cancer,2018
2. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy;Chang;Leukemia,2003
3. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches;De Luca;Expert Opin. Ther. Targets,2012
4. Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia;Del Principe;haematologica,2016
5. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122;Gebert;Nucleic Acids Res.,2014
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In‐silico and in‐vitro evidence suggest LINC01405 as a sponge for miR‐29b and miR‐497‐5p, and a potential regulator of Wnt, PI3K, and TGFB signaling pathways in breast carcinoma;Cancer Reports;2024-01-15
2. ErbB4-encoded novel miRNAs act as tumor suppressors by regulating ErbB/PI3K signaling;Tumor Biology;2022-11-24
3. SPTBN1 attenuates rheumatoid arthritis synovial cell proliferation, invasion, migration and inflammatory response by binding to PIK3R2;Immunity, Inflammation and Disease;2022-11-16
4. B-Cell Translocation Gene 2 Upregulation Is Associated with Favorable Prognosis in Lung Adenocarcinoma and Prolonged Patient Survival;Journal of Oncology;2022-09-14
5. miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer;Frontiers in Oncology;2022-08-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3